Delta bilirubin in serum of pediatric patients: correlations with age and disease

Clinical Chemistry
|September 1, 1984
PubMed

Insights

The "delta" bilirubin fraction (B delta), bound to albumin, varies with age and disease. High B delta indicates cholestasis in newborns, while low B delta suggests poor prognosis in older children with certain conditions.

Area of Science:

  • Clinical Chemistry
  • Pediatric Gastroenterology
  • Neonatology

Background:

  • Bilirubin metabolism is complex, with several fractions identifiable by liquid chromatography.
  • The delta bilirubin fraction (B delta), covalently bound to albumin, is less understood.
  • Accurate assessment of bilirubin fractions is crucial for diagnosing and managing liver and hematologic disorders in children.

Purpose of the Study:

  • To investigate the incidence and clinical significance of the delta bilirubin fraction (B delta) in infants and children.
  • To correlate B delta levels with patient age and disease course.
  • To evaluate the potential interference of B delta with routine bilirubin assays.

Main Methods:

  • Serum samples from 539 infants and children were analyzed.
  • Liquid chromatography was used to separate and quantify bilirubin fractions, including B delta.
  • Results were compared with the routine colorimetric Jendrassik-Grof method.

Main Results:

  • B delta proportion generally was <2% in infants <28 days old.
  • Median B delta was 35% in hyperbilirubinemic older infants and children.
  • High B delta (>50%) in newborns was linked to cholestasis and biliary disorders.
  • Low B delta (<10%) in older children was associated with hemolytic anemias, sepsis, and shock.
  • Low B delta with increased conjugated bilirubin indicated a poor prognosis.

Conclusions:

  • The delta bilirubin fraction (B delta) levels correlate with age and disease status in pediatric populations.
  • Elevated B delta is indicative of cholestatic conditions in newborns.
  • Low B delta, particularly with elevated conjugated bilirubin, may signify a poor prognosis in older children.
  • The presence and clearance rate of B delta can impact the interpretation of conjugated bilirubin measurements by standard methods.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...